Forbion, already one of Europe’s largest life sciences venture capital firms, now has more investment firepower with...
BioPharma
The growth strategy of Shionogi & Co. is picking up a new piece through the $2 billion...
Immune reset has become a particularly active area of immunology R&D as companies develop therapies intended to...